Filtros de búsqueda

Lista de obras de Fernando Cabanillas

16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma

artículo científico publicado en 1995

9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma

artículo científico publicado en 1986

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

artículo científico publicado el 1 de febrero de 1992

A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma

A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity

artículo científico publicado en 1993

A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma

artículo científico publicado en 2007

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas

artículo científico publicado en 1994

A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma

artículo científico publicado en 2005

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

artículo científico

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

scientific article published on 01 November 1999

Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma

artículo científico publicado el 1 de mayo de 1998

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease

artículo científico publicado en 2002

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

artículo científico publicado en 2003

Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy

artículo científico publicado en 1993

Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma

artículo científico publicado en 1999

Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections

scientific article published on 01 September 2002

Asymptomatic Waldenstrom's macroglobulinemia.

artículo científico publicado en 2003

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

artículo científico publicado en 2002

Benign Fibrous Histiocytoma in Hodgkin's Disease

artículo científico publicado el 1 de enero de 1984

CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome

artículo científico publicado en 2002

Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study

artículo científico publicado en 2003

Check this checkpoint inhibitor in lymphoma

artículo científico publicado en 2017

Chemotherapy as definitive treatment of stage I-II large cell and diffuse mixed lymphomas

scientific article published on 01 January 1985

Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma

artículo científico publicado en 1988

Chromosome 17- and p53 changes in lymphoma.

artículo científico publicado en 1991

Chromosome X numerical abnormalities in patients with non-Hodgkin's lymphoma. A study of 59 patients using fluorescence in situ hybridization

scientific article published on 01 July 1995

Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's disease.

artículo científico publicado en 1993

Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease

artículo científico publicado en 1997

Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment

scientific article published on 01 May 2001

Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells

artículo científico publicado en 1998

Coincident renal cell carcinoma and nonHodgkin's lymphoma: the M. D. Anderson experience and review of the literature

artículo científico publicado el 1 de marzo de 1998

Combined modality therapy for cutaneous T-cell lymphoma

artículo científico publicado en 1996

Curability of Advanced Indolent or Low-Grade Follicular Lymphomas: Time for a New Paradigm?

artículo científico publicado el 8 de octubre de 2012

Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma

scientific article published on 01 August 2000

Dose dense CHOP: when more is not always better!

artículo científico publicado en 2007

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

artículo científico publicado en 2001

Effective combination chemotherapy of adult malignant histiocytosis (histiocytic medullary reticulosis).

artículo científico publicado en 1978

Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units

artículo científico publicado en 1984

Elevated Serum Levels of IL-10 are Associated with Inferior Progression-Free Survival in Patients with Hodgkin's Disease Treated with Radiotherapy

scientific article published on 01 October 2004

Establishment and characterization of a new mantle cell lymphoma cell line M-1.

artículo científico publicado en 2004

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.

artículo científico publicado en 2002

Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.

artículo científico publicado en 2004

Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance

artículo científico publicado en 2002

Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma

artículo científico publicado el 1 de marzo de 1978

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma

artículo científico publicado en 2002

Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981

artículo científico publicado en 2000

Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma

artículo científico publicado en 2003

Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfilgrastim as support

artículo científico publicado en 2012

Front-line management of diffuse large B cell lymphoma

artículo científico publicado el 1 de noviembre de 2010

Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.

artículo científico publicado en 2001

Granulocyte Colony-Stimulating Factor in Afebrile Patients with Neutropenia

artículo científico publicado el 30 de octubre de 1997

High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma

scientific article published on 01 July 1986

High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement

artículo científico publicado en 1994

High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication

artículo científico publicado en 2006

High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study

artículo científico publicado en 2017

High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies

scientific article published on 01 June 1986

Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria

artículo científico publicado en 1999

Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II.

artículo científico publicado en 1998

How important is whole brain radiotherapy for treatment of primary CNS lymphoma?

artículo científico publicado el 20 de octubre de 2010

Human B cell lymphomas: in vitro and in vivo studies on growth factors and cell growth.

artículo científico publicado en 1993

Human central nervous system pharmacology of pentamethylmelamine and its metabolites

artículo científico publicado en 1983

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

artículo científico publicado en 2005

Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas

artículo científico publicado en 2000

Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma

artículo científico publicado en 2003

Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: A prognostic factor comparison of two regimens

artículo científico publicado el 1 de enero de 1978

Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center

scientific article published on 01 April 2006

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Indolent Lymphomas That Present With Clinically Aggressive Features: A Subset of Low-Grade Lymphomas With a Behavior Inconsistent With the Histologic Diagnosis.

artículo científico publicado en 2016

Intensive induction chemotherapy of extensive small cell bronchogenic carcinoma in protected environment--prophylactic antibiotic units. A preliminary report

scientific article published on 01 August 1980

Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

scientific article published on 01 April 1999

Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers

artículo científico publicado en 2001

International prognostic index-based outcomes for diffuse large B-cell lymphomas

artículo científico publicado en 2002

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?

artículo científico publicado en 2002

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

artículo científico publicado en 2012

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.

artículo científico publicado en 2000

Localized primary malignant lymphoma of bone

artículo científico publicado en 1997

Localized primary non-Hodgkin lymphoma of the breast

artículo científico publicado en 1998

Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated ag

artículo científico publicado en 2013

Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience

scientific article published on 01 October 1997

Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression

artículo científico publicado en 1997

Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies

scientific article published on 01 October 1997

Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.

artículo científico publicado en 2017

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma

artículo científico publicado en 2003

Long-term results of treatment of patients with follicular lymphomas.

artículo científico publicado en 1987

Long-term results with radiotherapy for Stage I-II follicular lymphomas

artículo científico publicado en 2001

Lymphomatous presentation of CD4+/CD8+ HTLV-1-related adult T-cell leukemia/lymphoma in an Iranian woman

artículo científico publicado en 1994

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB).

artículo científico publicado en 2004

Mantle Cell Lymphoma with t(11;22) (q13;q11.2) an indolent clinical variant?

artículo científico publicado en 2018

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure

scientific article published on 01 July 2001

Mantle-cell lymphoma

scientific article published on 01 March 2001

Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).

artículo científico publicado en 2004

Monosomy 21, partial duplication of chromosome 11, and structural abnormality of chromosome 1q21 in a case of lymphoma developing in a transplant recipient: characteristic abnormalities of secondary lymphoma?

artículo científico publicado en 1987

Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression

artículo científico publicado en 2000

Nephrotoxicity of combined cephalothin-gentamicin regimen

artículo científico publicado el 1 de junio de 1975

New developments in the field of diffuse large cell lymphoma

artículo científico publicado en 2012

Non-Hodgkin's lymphoma: the old and the new.

artículo científico

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

artículo científico publicado el 15 de diciembre de 2001

Outcome of Hodgkin's disease in elderly patients

scientific article published on 01 January 1995

Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma

artículo científico publicado en 2004

Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma

scientific article published on 01 June 1998

Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas

scientific article published on 01 September 2002

Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma

artículo científico publicado en 1998

Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

artículo científico publicado en 2001

Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma

artículo científico publicado en 2008

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease

scientific article published on 01 August 2004

Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma

artículo científico publicado en 2014

Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

scientific article published on 01 January 1999

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

artículo científico publicado en 2004

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia

artículo científico publicado en 2006

Philadelphia chromosome without breakpoint cluster region rearrangement in a case of Lennert's lymphoma of suppressor phenotype

artículo científico publicado en 1989

Pixantrone: a new agent for relapsed aggressive lymphomas

artículo científico publicado en 2012

Polysomy of chromosome 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphoma

scientific article published on 01 March 1994

Primary Lymphoma of the Prostate: Good Outcome with Doxorubicin-Based Combination Chemotherapy

article

Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy

artículo científico publicado en 2003

Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement

artículo científico publicado en 2002

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

artículo científico publicado en 2004

Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.

artículo científico publicado en 2016

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.

artículo científico publicado en 2011

Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

artículo científico publicado en 2009

Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma

artículo científico publicado en 2002

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease

artículo científico publicado en 2002

Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease

artículo científico publicado el 1 de enero de 1992

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

artículo científico publicado en 2002

Recent advances in the management of mantle cell lymphoma.

artículo científico publicado en 2013

Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma

artículo científico publicado en 1989

Reply to I.E. Haines

artículo científico publicado en 2013

Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma

artículo científico publicado en 2002

Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma.

artículo científico publicado en 1995

Rituximab in DLBCL: 6 years on

artículo científico publicado el 21 de septiembre de 2011

Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center

artículo científico publicado en 2015

Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.

artículo científico publicado en 1999

Second malignancies after chemotherapy and radiotherapy for Hodgkin disease

artículo científico publicado en 2004

Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type

artículo científico publicado en 1983

Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation

artículo científico publicado en 1995

Simultaneous presentation of hairy cell leukemia and follicular small cleaved cell lymphoma in a patient with previous diagnosis of renal cell carcinoma

scientific article published on 01 March 1995

Stage III follicular lymphoma: long-term follow-up and patterns of failure.

artículo científico publicado en 2003

Study of the natural history of immunoblastic lymphadenopathy and atypical immunoproliferative disorders

artículo científico publicado en 1983

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors

artículo científico publicado en 1998

Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab

artículo científico publicado en 2011

T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease

artículo científico publicado en 1996

Thalidomide for patients with recurrent lymphoma

artículo científico publicado en 2004

The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma

artículo científico publicado en 2007

The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results

artículo científico publicado en 1988

The application of fluorescence-based PCR and PCR-SSCP to monitor the clonal relationship of cells bearing the t(14;18)(q32;q21) in sequential biopsy specimens from patients with follicle center cell lymphoma

scientific article published on 01 April 1997

The role of mitoxantrone in the treatment of indolent lymphomas.

artículo científico publicado en 2005

Therapeutic concepts in mantle cell lymphoma

artículo científico publicado en 2010

Trimetrexate in relapsed T-cell lymphoma with skin involvement.

artículo científico publicado en 2002

Unbalanced expression of Fas and CD40 in mantle cell lymphoma

scientific article published on 01 October 1998

Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma

artículo científico publicado en 2007

Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis

scientific article published on 27 July 2006

What constitutes a "cure" in lymphoma?

scientific article published on 01 October 1993